Ophthalmology & Vision

Glaucoma, cataracts, macular degeneration, and eye‑care technology updates.

  • 3 Tracked terms
  • Last 30 days Feed window

What this topic collects on

An article joins this feed when it matches these terms. Each one is also a search of its own.

Latest in Ophthalmology & Vision

nzoptics.co.nz
328 words

Strongest ever six-month Stellest 2.0 effects

EssilorLuxottica has reported six-month interim results from an ongoing randomised, double-masked clinical trial in China, in which Essilor Stellest 2.0 spectacle lenses achieved average treatment effects of 0.51D for myopia progression and 0.21mm for axial elongation, compared with single-vision lenses. However, the comparison…